CONTINUING EDUCATION

Information

In recent surveys, you greatly contributed and expressed your needs. We listened! 

The OnTarget team is proud to present a new modular learning activity format.

Active OnTarget users should simply log-in to their account for access to the modules. If you are not registered, we invite you to do so by clicking "REGISTER" at the top right corner of your screen. The account allows us to upload your certificates of completion. Once registered, you may navigate back to the "MENU" to access all modules.

Developed by the scientific committee, this new modular format, will enable learners to obtain between 1.25 and 2 CEUs per module. The new modules include:

Module I - Lung Cancer

Module II - Immunotherapy

Module III - Bispecifics

Module IV - Multiple Myeloma

The Canadian Council on Continuing Education in Pharmacy (CCCEP) has accredited these modules. You may consult the individual page of each module to find details pertaining to: 

  • The relevant chapters to consult and read for each module,
  • The module’s learning objectives,
  • The number of credits attributed when you have successfully completed the quiz, 
  • The passing grade,
  • The total time estimated to complete the module. 

For any questions or to contribute suggestions for future learning activities, please reach out to the OnTarget team via the “Contact” tab on the landing page. 

Program Learning Objectives

Upon reading the chapters of the OnTarget website, pharmacists will be able to:

  • Identify the key molecular targets of medications used for the treatment of cancer.
  • Identify the common adverse events of targeted cancer therapies, based on their specific target and the common adverse events of individual therapies.
  • Assess symptoms and apply the most appropriate management strategies to minimize impact on the patient's quality of life.
  • Educate and inform your patients about potential common adverse events.
  • Make appropriate referrals to oncologists or other healthcare professionals, when required.

For learning objectives pertaining to modules I to IV, please consult the module’s introduction section.

Disclosures of Potential Conflicts of Interests

The Scientific Committee

Jean-Philippe Adam, B. Pharm., M.Sc., BCPS, BCOP
Jean-Philippe Adam has received an honorarium from GlaxoSmithKline for a consultation regarding the commercialisation of belantamab mafodotine. This molecule is not part of the OnTarget resource. 

Annie Brisebois-Boyer, Pharm. D., M.Sc., BCOP
No conflict to disclose.

Marie-Pascale Guay, B. Pharm., M.Sc. BCOP 
Marie-Pascale Guay has received an honorarium for her participation in consult meetings for Knight Therapeutics, Organon Canada and AstraZeneca.

Nathalie Letarte, B Pharm., M.Sc., DESG, Pharm. D., BCOP
No conflict to disclose.

Scientific Reviewers

Bianca Déry-Neveu, B. Pharm., M.Sc., DESS in public health
No conflict to disclose.

Monica Khauv, B.Pharm., M.Sc in hospital pharmacy, BCOP
No conflict to disclose.

Module I - Lung Cancer

Active OnTarget users should simply log-in to their account for access to the modules. If you are not registered, we invite you to do so by clicking "REGISTER" at the top right corner of your screen. The account allows us to upload your certificates of completion. Once registered, you may navigate back to the "MENU" to access all modules.

Module II - Immunotherapy

Active OnTarget users should simply log-in to their account for access to the modules. If you are not registered, we invite you to do so by clicking "REGISTER" at the top right corner of your screen. The account allows us to upload your certificates of completion. Once registered, you may navigate back to the "MENU" to access all modules.

Module III - Bispecifics

Active OnTarget users should simply log-in to their account for access to the modules. If you are not registered, we invite you to do so by clicking "REGISTER" at the top right corner of your screen. The account allows us to upload your certificates of completion. Once registered, you may navigate back to the "MENU" to access all modules.

Module IV - Multiple Myeloma

Active OnTarget users should simply log-in to their account for access to the modules. If you are not registered, we invite you to do so by clicking "REGISTER" at the top right corner of your screen. The account allows us to upload your certificates of completion. Once registered, you may navigate back to the "MENU" to access all modules.